Optiver Holding’s Astria Therapeutics ATXS Stock Holding History

Optiver Holding’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-174	Closed	-$2.28K	–	2333
2025 Q4	$2.28K	Buy	174 +86	+98%	+$1.03K	﹤0.01%	1943
2025 Q3	$641	Buy	+88	New	+$596	﹤0.01%	2540

Optiver Holding's ATXS Position: Q1 2026 in Review

Optiver Holding sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 174 shares — an estimated $2.28K sold.

Optiver Holding first reported a position in ATXS in Q3 2025 and held it in 2 quarters. The position peaked at $2.28K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Optiver Holding reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Optiver Holding sold 174 Astria Therapeutics shares in Q1 2026, an estimated $2.28K.
Optiver Holding first reported a position in Astria Therapeutics in Q3 2025 and held it in 2 quarters.
Optiver Holding's Astria Therapeutics position peaked at $2.28K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.